Wednesday, August 10, 2022
Home Biotech News Exsosomes

Exsosomes

    Random

    Adding Brainstorm Therapeutics (BCLI) $4.59 to CoronaVirus Watchlist.

    Exsosomes Editor / Curator -
    This is a company exploring the use of stem cells for a number of ailments. The lead program is (or was) for...
    Organicell

    Organicell (BPSR) a Triple Since Easter.

    Infections Editor / Curator -
    Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR)...
    Organicell

    Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.

    Superbug News - CoronaVirus Watch List Editor / Curator -
    Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what...

    Stem Cell Play Organicell (BPSR) Screams Higher.

    Exsosomes Editor / Curator -
    Stock Levitates After Series of Positive Press Releases on Zofrin. Added to the Watch List in April a...

    Latest article

    Hagerty Garage and Social

    Private Investor Meetup with Football Star Tim Wright.

    All News Editor / Curator -
    Saturday August 6th, Delray Beach Exclusive cocktail hour with Super Bowl Champion and Dome Audio Founder Tim Wright.

    What is NAC (N-Acetyl-L-Cysteine)? (Dr Eric Berg)

    Biotech News Editor / Curator -
    https://youtu.be/oPdGOrqTfhA What is NAC good for? (and How Much to Take?)

    FDA Issues Final ‘Enforcement Discretion’ Guidance on NAC.

    Biotech News Editor / Curator -
    NAC Crosses Major Hurdle With FDA. Is Bucillamine Next. Josh Long | Aug 01, 2022 "Industry, and...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: roland@institutionalanalyst.com
    © Managed by Revelers.IO Media Group Inc.